Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: A systematic review and meta-analysis

被引：0

作者：

Schipilliti, F. M. ^{[1
]}

Rizzo, A. ^{[2
]}

Di Costanzo, F. ^{[3
]}

Acquafredda, S. ^{[4
]}

Arpino, G. ^{[5
]}

Puglisi, F. ^{[6
]}

Del Mastro, L. ^{[7
]}

Montemurro, F. ^{[8
]}

De Laurentiis, M. ^{[9
]}

Giuliano, M. ^{[10
]}

机构：

[1] St Andrea Univ Hosp, Dept Oncol, Rome, Italy

[2] Ist Tumori Bari Giovanni Paolo II IRCCS, Dept Oncol, Bari, Italy

[3] Azienda Osped Univ Federico II, Oncol Med, Naples, Italy

[4] Policlin Bari Osped Giovanni XXIII, Dipartimento Oncol, Bari, Italy

[5] Univ Napoli Federico II, Dept Oncol, Dipartimento Farm, Naples, Italy

[6] Osped S Maria Misericordia, Dept Med Oncol, ASU Friuli Cent, Udine, Pordenone, Italy

[7] IRCCS Osped Policlin San Martino, Dept Internal Med, Genoa, Italy

[8] IRCCS Ist Candiolo FPO, Investigat Clin Oncol Dept, Candiolo, TO, Italy

[9] Ist Nazl Tumori IRCCS Fdn G Pascale, Dept Breast & Thorac Oncol, Naples, Italy

[10] AOU Federico II, Dept Oncol, Naples, Italy

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.463

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

266P

引用

页码：S289 / S289

页数：1

共 50 条

[21] Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis
Yuanfang Xin
Guoshuang Shen
Yonghui Zheng
Yumei Guan
Xingfa Huo
Jinming Li
Dengfeng Ren
Fuxing Zhao
Zhen Liu
Zitao Li
Jiuda Zhao
BMC Cancer, 21
[22] Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis
Xin, Yuanfang
Shen, Guoshuang
Zheng, Yonghui
Guan, Yumei
Huo, Xingfa
Li, Jinming
Ren, Dengfeng
Zhao, Fuxing
Liu, Zhen
Li, Zitao
Zhao, Jiuda
BMC CANCER, 2021, 21 (01)
[23] Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis
Tian, Muyou
Zhong, Yahua
Zhou, Fuxiang
Xie, Conghua
Zhou, Yunfeng
Liao, Zhengkai
ONCOLOGY LETTERS, 2015, 9 (06) : 2825 - 2832
[24] Transcriptome Meta-Analysis of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy
Zhang, Wei
Li, Emma
Wang, Lily
Lehmann, Brian D. D.
Chen, X. Steven
CANCERS, 2023, 15 (08)
[25] The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis
Petrelli, Fausto
Coinu, Andrea
Borgonovo, Karen
Cabiddu, Mary
Ghilardi, Mara
Lonati, Veronica
Barni, Sandro
BREAST CANCER RESEARCH AND TREATMENT, 2014, 144 (02) : 223 - 232
[26] The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis
Fausto Petrelli
Andrea Coinu
Karen Borgonovo
Mary Cabiddu
Mara Ghilardi
Veronica Lonati
Sandro Barni
Breast Cancer Research and Treatment, 2014, 144 : 223 - 232
[27] Adverse Events of PD-1 or PD-L1 Inhibitors in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
Zhang, Yixi
Wang, Jingyuan
Hu, Taobo
Wang, Huina
Long, Mengping
Liang, Baosheng
LIFE-BASEL, 2022, 12 (12):
[28] Third-line Treatment for Metastatic Triple-negative Breast Cancer: A Systematic Review and Network Meta-analysis
Shi, Mingqiang
Li, Zhoujuan
Wang, Tianzhuo
Wang, Miaozhou
Liu, Zhen
Zhao, Fuxing
Ren, Dengfeng
Zhao, Jiuda
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (02): : 91 - 98
[29] TARGETED THERAPY IN TRIPLE-NEGATIVE METASTATIC BREAST CANCER (TNBC) - A SYSTEMATIC REVIEW AND META-ANALYSIS
Clark, O. A. C.
Engel, T.
Paladini, L.
Ferreira, M. B. A.
VALUE IN HEALTH, 2013, 16 (07) : A394 - A394
[30] Efficacy and safety analysis of AKT inhibitor in triple-negative breast cancer: A meta-analysis and systematic review
Yang, Minghao
Wang, Chunxi
Chen, Guoping
Zhang, Haowen
Lin, Junlong
MEDICINE, 2024, 103 (35)

← 1 2 3 4 5 →